Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
yangxue qingnao granules
- Development stage
- Unknown
- Lead developer
- Tasly Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Yangxue Qingnao granules is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Tasly Pharmaceutical Group. It is primarily indicated for the treatment of headaches, including migraine and tension-type headache, as well as dizziness and chronic cerebral circulation insufficiency (CCCI). The formulation is composed of eleven herbal ingredients: *Angelica sinensis*, *Ligusticum chuanxiong*, *Paeonia lactiflora*, *Rehmannia glutinosa*, *Uncaria rhynchophylla*, *Cassia seed*, *Spatholobus suberectus*, *Prunella vulgaris*, *Concha Margaritifera Usta*, *Corydalis yanhusuo*, and *Schisandra chinensis*. Its therapeutic effects are attributed to its ability to improve cerebral blood flow, inhibit platelet aggregation, and modulate neurotransmitter systems, particularly the serotonergic pathway. In clinical practice, it is frequently used as both a monotherapy and an adjunctive treatment for headache disorders and associated comorbidities, such as those found in patients with epilepsy or hypertension.
- Brand names
- Yangxue Qingnao Granules
- Other names
- Yangxue Qingnao KeliYXQN
02
Targets
5-HT (Serotonin receptors)
Beyond the preview
Go deeper on yangxue qingnao granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on yangxue qingnao granules.